Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L. Kavali
Sofosbuvir and Ledipasvir in Attainment of SVR12 in Sickle Cell Disease (SCD) Sub-Population With Chronic Hepatitis C (CHC). A Single Center Prospective Study-Slash C Trial
HPB
Hepatology
Gastroenterology
Related publications
Kidney Transplant Recipients With Hepatitis C Virus Experienced 100% SVR12 Rate When Treated With Sofosbuvir-Ledipasvir
Hepatology
Medicine
Hepatology
Ledipasvir/Sofosbuvir Effectively Treats Hepatitis C Virus Infections in an Underserved Population
Digestive Diseases and Sciences
Physiology
Gastroenterology
Cost Effectiveness Analysis of Sofosbuvir and Ledipasvir/Sofosbuvir in Hepatitis C Virus (HCV) Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Ledipasvir and Sofosbuvir for Recurrent Hepatitis C After Liver Transplantation
BioScience Trends
Biochemistry
Health
Medicine
Genetics
Molecular Biology
Sofosbuvir Plus Ledipasvir for Recurrent Hepatitis C in Liver Transplant Recipients
Liver Transplantation
Hepatology
Transplantation
Surgery
Treatment of Viral Hepatitis C by the Sofosbuvir and Ledipasvir With or Without Ribavirin Combination in Cameroon: Efficiency, Tolerance and Significant Predictors of SVR12
Clinical Infection and Immunity
Ledipasvir and Sofosbuvir for Hepatitis C Genotype 4: A Proof-Of-Concept, Single-Centre, Open-Label Phase 2a Cohort Study
The Lancet Infectious Diseases
Infectious Diseases
Daclatasvir and Sofosbuvir Therapy Enhance Monocyte Phenotypic Changes in Naive Chronic Hepatitis C Patients: A Prospective Cohort Study
Interdisciplinary Perspectives on Infectious Diseases
Virology
Parasitology
Infectious Diseases
Microbiology
Efficacy and Safety of Ribavirin With Sofosbuvir Plus Ledipasvir in Patients With Genotype 1 Hepatitis C: A Meta-Analysis
Digestive Diseases and Sciences
Physiology
Gastroenterology
